logo
China is arming its space station with ‘guard dogs.' They have good reason for it

China is arming its space station with ‘guard dogs.' They have good reason for it

Fast Company21 hours ago

China is developing robotic guards for its Tiangong space station. Equipped with small thrusters, these AI-powered robotic beasts are being developed to intercept and physically shove suspicious objects away from its orbital outpost. It's a deceptively simple but ingenious step towards active space defense in an increasingly militarized domain. Rather than firing directed energy weapons like lasers or projectiles, which will turn the potential invader into a cloud of deadly shrapnel flying at 21 times the speed of sound, the Chinese have thought of a very zen 'reed that bends in the wind' kind of approach. The bots will grapple a threatening object and lightly push it out of harm's way. Elegant space jiu-jitsu rather than brute kickboxing.
The announcement, made by scientist Sun Zhibin of China's National Space Science Centre during a recent talk at Nanjing University of Science and Technology, comes as recent Pentagon reports reveal that China has already staged the first-ever satellite combat operations in low-Earth orbit. It marks a decisive shift from passive space exploration and coexistence to active territorial control at orbital altitudes.
Beijing indicates that it is not 'arming' its space station out of aggression, but as a response to recent threats by a Starlink satellite, which grazed the Tiangong, prompting evasive maneuvers and strong formal protest in the UN by the Chinese delegation. However, it would be naive not to see it as part of the ongoing effort to dominate space by force, which is now ongoing in Russia, the United States, and China.
A logical design
China's solution is actually the only possible design that makes sense. On Earth, when you destroy an aerial object, it falls to the ground, where it stays forever thanks to gravity. But firing a projectile at an object approaching a space station wouldn't end a threat—it would unleash chaos.
Imagine this: A bullet, no larger than your fist, streaks toward an incoming satellite. They collide not with a Hollywood explosion, but a silent, hyper-violent shattering. At orbital speeds—10 times faster than a rifle round—the impact vaporizes metal, scattering a storm of razor-edged fragments in all directions. Each shard, now a new projectile, inherits the object's original velocity. Some scream toward the void; others carve lethal arcs back toward the station, peppering its hull like cosmic shotgun pellets.
This isn't just debris. It's a permanent minefield that doesn't go away. Those fragments don't slow down. They don't fall. They loop around Earth for decades, crossing orbits like invisible shrapnel. One piece tears through a solar panel, crippling a satellite. Another punches into a fuel tank, triggering a secondary explosion. The cascade begins: each new collision spawns more debris, more weapons. Low-Earth orbit—once a highway of discovery—becomes a junkyard of spinning blades, making space travel impossible for centuries to come. This doomsday scenario is what it's technically known as the Kessler effect, which was formulated in 1978 by NASA scientists Donald J. Kessler and Burton G. Cour-Palais.
Firing a laser—or any other form of directed energy beam—wouldn't stop the incoming object either (to be strictly correct, it would eventually, as light exerts a force on objects, but it would take years, so it's not useful for this defense scenario).
Sun's proposal, however, would theoretically work perfectly. First, it's not only about space robots. It outlines a tiered response protocol that transforms space station defense from reactive to proactive operations. When sensors and ground control detect an approaching object, the system initiates a comprehensive intent assessment phase, analyzing the intruder's trajectory, velocity changes, and behavioral patterns to determine whether the approach represents deliberate reconnaissance, accidental drift, or potential collision threat. The assessment feeds into a decision matrix that weighs multiple response options, ranging from subtle evasive maneuvers and orbital adjustments to the deployment of what Sun describes as specialized robotic thrusters—something I'm calling 'space guard dogs.'
These bots are the most cinematic capability of the defense, involving physical interception. You can think about these space guard dogs as autonomous directional thrusters like the ones that Apollo astronauts used to maneuver the Apollo Command Module or the Lunar Module. The engineers have not presented the design for these bots yet, but they describe small thrusters equipped with sensors, a docking mechanism, and artificial intelligence. After launching from the Tiangong and intercepting the suspicious object, the bot's docking mechanism— most likely a grapple —will latch onto the intruders. Once securely attached, the thrusters will fire in a controlled propulsion burn to push targets into safer trajectories, like a tugboat in a port, effectively creating a moveable exclusion zone around China's premier space asset.
'Sometimes another spacecraft may deliberately come close—maybe just to take a look—but it can still interfere with our operations,' Sun explained during his presentation, acknowledging that even ostensibly peaceful approaches can disrupt critical station operations.
The strategic rationale of the system is rooted in past incidents that have highlighted the vulnerabilities of orbital assets. In December 2021, China formally reported to the United Nations that its Tiangong space station was forced to perform two evasive maneuvers in the same year to avoid potential collisions with SpaceX's Starlink satellites. Starlink-1095 and Starlink-2305 reportedly descended from their typical operational orbits of around 555 kilometers into Tiangong's zone at approximately 382 kilometers, prompting emergency actions on July 1 and October 21, 2021.
The encounters were observed by Harvard astronomer Jonathan McDowell using U.S. space tracking data, estimating that the Starlink satellite in the October incident might have come within a mere 1.8 miles of the Tiangong station. In space distances, this is the equivalent of two cars coming within fractions of an inch from a crash. The near-misses occurred while astronauts were aboard the station, 'endangering the life or health of astronauts' according to Beijing. China stressed that states are responsible for all national space activities, including those conducted by commercial operators.
The Chinese complaint to the UN highlighted the difficulty in predicting the Starlink satellites' trajectories due to their continuous maneuvering, with their strategies largely unknown and orbital errors hard to assess, thus posing a collision risk. For the July 2021 encounter, there was no advance communication between SpaceX and the China Human Spaceflight Engineering Office (CMSEO) about the pass. SpaceX, for its part, confirmed that it checks for close approaches with both the International Space Station and China's Space Station.
The United States stated in response that these activities did not meet the threshold for established emergency collision criteria, and therefore, emergency notifications were not warranted. China disagreed, and the International Space Station—managed by the United States, Russia, and Europe— would have probably executed the same maneuver, according to past operational history.
This divergence in perspectives underscores a critical gap in international norms and communication protocols for space operations. The absence of clear, mutually agreed-upon rules for collision avoidance and maneuver notification between major spacefaring entities fosters an environment ripe for misinterpretation, accidental collisions, and escalating tensions, directly fueling the perceived need for 'space guard dog' capabilities and contributing to a more contested space domain. This is even more important when you take into consideration how all these global powers are actively putting weapons in space and training for space war contravening the Outer Space Treaty of 1967, the document that established international space law and prohibited placing nuclear weapons or other weapons of mass destruction in orbit, on celestial bodies, or in outer space.
Advantage China
China's protests in the UN are ironic given that China's ambitions in space extend far beyond its defensive robots. The country is quickly expanding military space operations, building capabilities that are reshaping the global space landscape. It founded its space force in 2024, declaring orbital operations the most crucial domain for the country's defense. This is nothing that the United States and Russia haven't been doing for decades. The Pentagon also has its own space force arm—founded by Trump in his first term—and has recently suggested to accelerate the country's efforts in response to China's latest developments.
One of the most concerning developments for the U.S. is China's demonstrated prowess in rendezvous and proximity operations (RPO), precise spacecraft maneuvers to approach and closely operate near another object satellite. These involve controlled relative motion for activities like inspection, maintenance, docking, or capture. They can be peaceful—like filling the fuel tank of a satellite—or military, like taking down another spaceship. U.S. Space Force officials have likened China's maneuvers to 'dogfighting in space,' a term that evokes Star Wars space battles but that actually occurs in a much different way, with long trajectories that take a long time to complete and none of that Luke versus Vader tit-for-tat. Vice Chief of Space Operations Gen. Michael A. Guetlein stated in March 2025 that China has been using experimental satellites to practice these dogfights, an event that has beaten the Pentagon's own plans to do the same.
The test involved a series of 'proximity operations' conducted in low-Earth orbit last year, involving 'five different objects in space maneuvering in and out and around each other in synchronicity, and in control.' There were three Shiyan-24C experimental satellites—think about these as the attackers—and two Shijian-6 05A/B experimental space objects—the targets—which came within less than roughly half a mile of each other. These operations are not just technical demonstrations; they are seen as 'practicing tactics, techniques, and procedures to do on-orbit space operations from one satellite to another,' the Space Force says, hinting at potential hostile intentions.
It is not the first time China has done it, too. The Shijian (meaning 'Practice' in Chinese) series of satellites has long been a focal point of concern for U.S. government and space observers due to their unannounced launches, deployment of undisclosed sub-satellites, and unusual orbital maneuvers. It has demonstrated RPO capabilities, including close inspection and even towing of other objects. The Shijian-17, launched in 2016, was equipped with a robotic arm. U.S. Space Command Commander General James H. Dickinson publicly warned in April 2021 that this robotic arm could be used in a 'future system for grappling other satellites,' highlighting its potential for 'counter space capabilities.' Which brings us back full circle to that idea of the space guard dogs and why Sun believes they need them.
The militarization of space
There have been previous military operations in space—most notably, the U.S. conducted several nuclear tests in space, like Starfish Prime in 1962, a 1.4 megaton bomb detonated at a high altitude over Johnston Atoll, an island in the Pacific Ocean, aimed to study the effects of EMP (Electromagnetic Pulse) on electronics and satellites. But things are getting really heated now.
The U.S. Space Force is playing catch up with Chinese capabilities. The U.S. Defense Advanced Research Projects Agency (DARPA) and the U.S. Space Force's Space Systems Command (SSC) are spearheading initiatives like the Victus Haze mission, which has already been delayed from mid-2025 to a late 2025 launch. Using only two spaceships, it aims to partially match the capabilities demonstrated by the Chinese.
More importantly, however, is President Trump's Golden Dome, an ambitious $175 billion plan to build a coast-to-coast missile defense shield over the U.S. that envisions hundreds or even thousands of satellites in orbit, equipped with advanced sensors and interceptors, including space-based lasers, that are designed to detect, track, and neutralize incoming hypersonic, ballistic, and space-based weapons. Critics warn that such a system, aspiring to make the U.S. invulnerable, could be perceived by adversaries as an attempt to undermine nuclear deterrence, thereby fueling a dangerous global arms race. Indeed, China is already developing counter-stealth materials designed to evade Golden Dome's detection capabilities.
Russia has been developing orbital anti-satellite (ASAT) weapons for years. U.S. officials have confirmed that Moscow is developing a nuclear weapon designed to target satellites, capable of producing a powerful electromagnetic pulse (EMP) upon detonation that could indiscriminately disable hundreds of government and commercial satellites in low Earth orbit. This threat is particularly concerning given the critical reliance of modern society on satellite infrastructure. The Pentagon further stated that Russia launched an anti-satellite vehicle into orbit in May 2024, placing it in the same orbit as a U.S. government satellite, and that the Kosmos-2553 spacecraft, launched in February 2022, contained components of Russia's anti-satellite nuclear weapons system.
China has clearly stated that they consider orbital space domination crucial to have military superiority on Earth. They have declared they want technological hegemony in hypersonic space weapons and so far they have achieved it, according to the Pentagon itself, which referred to its tests as 'close to Sputnik moment' back in 2021. William Schneider—a senior member of the Hudson Institute think tank— wrote in 2022 that China's new space hypersonic force is a 'system of systems' designed to beat the U.S.'s early warning capabilities, which detect any nuclear launches in the world. The Chinese People's Liberation Army doesn't try to hide its fight for orbital domination, as American Enterprise Institute's analyst Larry Wortzel highlighted as far back as 2007: 'In a China Military Science article, Major General Liu Jixian of the PLA Academy of Military Science paraphrases Kennedy this way: 'Whoever controls the universe controls our world; whoever controls space controls initiative in war.'' Now we are seeing the results of this vision.
Of course, the U.S. thinks the same, as chief of space operations for the U.S. Space Force said in March at the Air & Space Forces Association's Warfare Conference in Aurora, Colorado: 'We must think of space as a warfighting domain, rather than just a collection of support activities.' His thoughts are a summary of the new official Pentagon doctrine for military space operations—Space Force Doctrine Document 1, published back in April.
These developments, coupled with the deterioration of existing arms control frameworks like the New START Treaty—set to expire in February 2026 with no successor—and the suspension of U.S.-China arms control talks—back July 2024 over US arms sales to Taiwan—paint a grim picture of a space environment increasingly devoid of guardrails. A vacuum of agreed-upon norms and limitations creates a dangerous free-for-all, where each nation's perceived need for security drives a continuous cycle of innovation and counter-innovation, pushing towards an orbital arms race and bypassing or ignoring the Outer Space Treaty.
Aside from Russia's alleged new nuclear satellite, spaceships like the ones used in Victus Haze or Tiangong's defensive robots operate within a legal gray area that exploits ambiguities in the 1967 Outer Space Treaty, which prohibits placing weapons of mass destruction in space, but doesn't say anything about conventional defensive systems. By framing the robots as nondestructive 'tugboats' rather than weapons, China maintains plausible deniability while establishing operational precedents that could normalize active space defense measures.
But, as we know, RPO capabilities have offensive applications too: The same robotic systems capable of pushing away threats could theoretically capture or disable hostile satellites through controlled manipulation. Sun's acknowledgment that satellites sometimes approach 'deliberately' to 'take a look' reflects growing concerns about orbital espionage, where nations deploy satellites for close-range intelligence gathering against foreign space assets.
The development signals that space warfare has moved beyond theoretical planning into operational reality, with the three top world powers now fielding systems capable of engaging hostile targets across the orbital domain. In this emerging environment, the line between defensive maneuvering and offensive action becomes increasingly blurred. And with it, the risk of actual space war—which could signal the start of a nuclear war on the ground—becomes clearer by the day.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Kelun-Biotech Announces Breakthrough Therapy Designation Granted for Sacituzumab Tirumotecan (Sac-TMT) in Combination With Tagitanlimab in China for Certain Types of Non-Small Cell Lung Cancer
Kelun-Biotech Announces Breakthrough Therapy Designation Granted for Sacituzumab Tirumotecan (Sac-TMT) in Combination With Tagitanlimab in China for Certain Types of Non-Small Cell Lung Cancer

Yahoo

time3 hours ago

  • Yahoo

Kelun-Biotech Announces Breakthrough Therapy Designation Granted for Sacituzumab Tirumotecan (Sac-TMT) in Combination With Tagitanlimab in China for Certain Types of Non-Small Cell Lung Cancer

CHENGDU, China, June 10, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") today announced that its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) (佳泰莱®) in combination with the PD-L1 monoclonal antibody tagitanlimab (科泰莱®) was granted Breakthrough Therapy Designation by the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) of China for the first-line treatment of locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) without actionable genomic alterations. Breakthrough Therapy Designation is granted for treatment options that demonstrate significant clinical advantages over currently available treatments and is aimed at expediting the research, development and marketing of innovative treatment options that address clinically urgent medical needs. This designation is based on the efficacy and safety data from the non-squamous cohort of the Phase II OptiTROP-Lung01 study. This marks the fifth Breakthrough Therapy Designation granted to sac-TMT by the NMPA. Sac-TMT has previously received this designation for: Locally advanced or metastatic triple-negative breast cancer (TNBC) in July 2022; EGFR-mutant, locally advanced or metastatic NSCLC after progression on EGFR-TKI therapy in January 2023; Locally advanced or metastatic hormone-receptor positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-) breast cancer (BC) in patients who have previously received at least two lines of systemic chemotherapy in June 2023; First-line treatment of unresectable locally advanced, recurrent or metastatic PD-L1 negative TNBC in March 2024. Results from a Phase 2 OptiTROP-Lung01 study of sac-TMT in combination with tagitanlimab in first-line advanced or metastatic non-squamous NSCLC patients were presented in a poster session at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting[1]. Dr. Michael Ge, CEO of Kelun-Biotech said, "This designation by the NMPA highlights the importance of developing novel therapeutic options for diverse NSCLC subtypes. Sac-TMT in combination with tagitanlimab demonstrated clinically meaningful outcomes in key endpoints for patients with non-squamous NSCLC without actionable genomic alterations as a first-line treatment. We are excited about the therapeutic potential of TROP2 ADC- immunotherapy combinations, and we look forward to working with regulatory authorities in China to bring this combination therapy to patients in need as soon as possible." [1] Abstract #8529: Lung Cancer – Non-Small Cell Metastatic, ASCO Annual Meeting, 2025 About sac-TMT (佳泰莱®)Sac-TMT, a core product of the Company, is a novel human TROP2 ADC in which the Company has proprietary intellectual property rights, targeting advanced solid tumors such as NSCLC, BC, gastric cancer (GC), gynecological tumors, among others. Sac-TMT is developed with a novel linker to conjugate the payload, a belotecan-derivative topoisomerase I inhibitor with a drug-to-antibody-ratio (DAR) of 7.4. Sac-TMT specifically recognizes TROP2 on the surface of tumor cells by recombinant anti-TROP2 humanized monoclonal antibodies, which is then endocytosed by tumor cells and releases KL610023 intracellularly. KL610023, as a topoisomerase I inhibitor, induces DNA damage to tumor cells, which in turn leads to cell-cycle arrest and apoptosis. In addition, it also releases KL610023 in the tumor microenvironment. Given that KL610023 is membrane permeable, it can enable a bystander effect, or in other words kill adjacent tumor cells. In May 2022, the Company licensed the exclusive rights to MSD (the tradename of Merck & Co., Inc., Rahway, NJ, USA) to develop, use, manufacture and commercialize sac-TMT in all territories outside of Greater China (includes Mainland China, Hong Kong, Macao, and Taiwan). To date, two indications for sac-TMT have been approved and marketed in China for the treatment of adult patients with unresectable locally advanced or metastatic TNBC who have received at least two prior systemic therapies (at least one of them for advanced or metastatic setting) and EGFR mutation-positive locally advanced or metastatic non-squamous NSCLC following progression on EGFR-TKI therapy and platinum-based chemotherapy. Sac-TMT became the first domestic ADC with global intellectual property rights to be fully approved for marketing. It is also the world's first TROP2 ADC to be approved for marketing in a lung cancer indication. In addition, two new indication applications for sac-TMT for the treatment of adult patients with EGFR-mutant locally advanced or metastatic NSCLC who progressed after treatment with EGFR-TKI therapy and with unresectable locally advanced, metastatic HR+/HER2- BC who have received prior endocrine therapy and other systemic treatments in the advanced or metastatic setting were accepted by the CDE, and were included in the priority review and approval process. As of today, the Company has initiated 8 registrational clinical studies in China. MSD has initiated 14 ongoing Phase 3 global clinical studies of sac-TMT as a monotherapy or with pembrolizumab2 or other agents for several types of cancer. These studies are sponsored and led by MSD. About Tagitanlimab (科泰莱®)Tagitanlimab is the first PD-L1 mAb globally to receive authorization for the first-line treatment of NPC. Previously, the NMPA has approved the marketing in China of tagitanlimab used in combination with cisplatin and gemcitabine for the first-line treatment of patients with R/M NPC and monotherapy for the treatment of patients with recurrent or metastatic NPC who have failed after prior 2L+ chemotherapy, respectively. About Kelun-BiotechKelun-Biotech ( is a holding subsidiary of Kelun Pharmaceutical ( which focuses on the R&D, manufacturing, commercialization and global collaboration of innovative biological drugs and small molecule drugs. The company focuses on major disease areas such as solid tumors, autoimmune, inflammatory, and metabolic diseases, and in establishing a globalized drug development and industrialization platform to address the unmet medical needs in China and the rest of world. The Company is committed to becoming a leading global enterprise in the field of innovative drugs. At present, the Company has more than 30 ongoing key innovative drug projects, of which 3 projects have been approved for marketing, 1 project is in the NDA stage, and more than 10 projects are in the clinical stage. The company has established one of the world's leading proprietary ADC platforms, OptiDC™, and has 1 ADC project approved for marketing, 1 ADC project in NDA stage, and multiple ADC and novel DC assets in clinical or preclinical research stage. For more information, please visit Media: klbio_pr@ View original content to download multimedia: SOURCE Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Jim Cramer on GE Vernova (GE): 'GE Vernova Has Installed 240 Gas Turbines in China'
Jim Cramer on GE Vernova (GE): 'GE Vernova Has Installed 240 Gas Turbines in China'

Yahoo

time3 hours ago

  • Yahoo

Jim Cramer on GE Vernova (GE): 'GE Vernova Has Installed 240 Gas Turbines in China'

We recently published a list of . In this article, we are going to take a look at where GE Vernova Inc. (NYSE:GEV) stands against other stocks that Jim Cramer discusses. Discussing GE Vernova Inc. (NYSE:GEV), Cramer said: 'So, how could the president turn around these negotiations with the Chinese? Okay, so I've been thinking about this. I always like to be constructive. I'm a constructive fella… Hey, how about turbines from power players? GE Vernova has installed 240 gas turbines in China, there you go, for about 50 million a pop. Just servicing these turbines gives us some cards to play. A technician doing maintenance on a carrier-grade router, emphasizing the company's technical capabilities. GE Vernova (NYSE:GEV) supplies technology for generating, moving, converting, and storing electricity, with a focus on gas, nuclear, wind, and digital power solutions. The company's products are built to upgrade energy systems and support cleaner power infrastructure. Overall, GEV ranks 3rd on our list of stocks that Jim Cramer discusses. While we acknowledge the potential of GEV as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Tech stocks inch up as Meta reportedly nears multibillion-dollar AI investment
Tech stocks inch up as Meta reportedly nears multibillion-dollar AI investment

Yahoo

time3 hours ago

  • Yahoo

Tech stocks inch up as Meta reportedly nears multibillion-dollar AI investment

The S&P 500 rose 0.55% on Tuesday as tech stocks, including Meta and Google, ticked upward. Tariffs may be leaving a cloud over the stock market, but tech companies continue their upward climb, buoyed by investor excitement around artificial intelligence. On Tuesday, Meta's share price rose 1.20% amid reports that Mark Zuckerberg's social media giant planned to invest around $15 billion into the startup Scale AI. Meta wasn't the only tech company to receive a boost on Tuesday. Apple shares rose 0.61%, despite a lackluster performance at its annual developer conference, while Tesla rebounded 5.67% as the public spat between Elon Musk and President Donald Trump has become more muted. Overall, the S&P 500 rose 0.55%. Despite markets remaining in the green, investors remain cautious as trade talks between the U.S. and China continued in London. Commerce Secretary Howard Lutnick told reporters on Tuesday that discussions with Chinese economic officials were going well. 'We're spending lots of time together,' he said. Meta has retained its status as one of the topmost U.S. tech companies, despite high profile stumbles over the past few years. Those include its disastrous pivot to the metaverse, and its more recent scramble to keep pace in the AI arms race with competitors, including Google and OpenAI. In its latest bid to shore up resources, Meta is building a new 'superintelligence' AI research lab—a term for an AI system that would surpass the collective intelligence of humanity—that will likely be headed by the 28-year-old billionaire founder of Scale AI, Alexandr Wang. According to reports from Bloomberg and The Information, the deal to bring Wang on board would entail an investment into Scale AI totaling around $15 billion. Though the move may not be enough for Meta to compete with other AI labs, the company's stock still ticked up by 1.20%, bringing its monthly gain to 9.85%. Google rose by 1.29% on Tuesday. As for Tesla, despite Tuesday's bump, Tesla has still fallen by 5.55% over the past week. The company is planning to launch its long-anticipated self-driving taxi service in Austin by the end of the month. Another red-hot tech stock, the stablecoin company Circle, maintained most of its massive gains from its initial public offering last week, hovering around $105, though it dropped 8.31% on the day. As Congress inches closer to passing landmark legislation that would establish regulation for stablecoins, a type of dollar-backed cryptocurrency, Circle had the largest two-day pop for an IPO that raised more than $500 million since 1980. Analysts said that Circle's performance could encourage other fintech and crypto companies to go public, with the exchange Gemini announcing that it had confidentially filed for its IPO last week. This story was originally featured on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store